UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Fevipiprant, an oral prostaglandin DP2 receptor (CRTh2) antagonist, in allergic asthma uncontrolled on low-dose inhaled corticosteroids

The European respiratory journal, 2017-08, Vol.50 (2), p.1700670-1700670

2017

Volltextzugriff (PDF)

Ge (100) and (111) N- and P-FETs With High Mobility and Low- T Mobility Characterization

IEEE transactions on electron devices, 2009-04, Vol.56 (4), p.648-655

2009

Volltextzugriff (PDF)

Ge-Interface Engineering With Ozone Oxidation for Low Interface-State Density

IEEE electron device letters, 2008-04, Vol.29 (4), p.328-330

2008

Volltextzugriff (PDF)

Ligelizumab treatment for severe asthma: learnings from the clinical development programme

Clinical & translational immunology, 2021, Vol.10 (3), p.e1255-n/a

2021

Volltextzugriff (PDF)

One time a day mometasone/indacaterol fixed-dose combination versus two times a day fluticasone/salmeterol in patients with inadequately controlled asthma: pooled analysis from PALLADIUM and IRIDIUM studies

BMJ open respiratory research, 2021-08, Vol.8 (1), p.e000819

2021

Volltextzugriff (PDF)

Confidence intervals for exposure‐adjusted rate differences in randomized trials

Pharmaceutical statistics : the journal of the pharmaceutical industry, 2022-01, Vol.21 (1), p.103-121

2022

Volltextzugriff (PDF)

Periodic Analysis of Resistive Random Access Memory (RRAM)-Based Swish Activation Function

SN computer science, 2022-05, Vol.3 (3), p.202, Article 202

2022

Volltextzugriff (PDF)

SiGe optoelectronic metal-oxide semiconductor field-effect transistor

Optics letters, 2007-07, Vol.32 (14), p.2022

2007

Volltextzugriff (PDF)

Once-daily, single-inhaler mometasone–indacaterol–glycopyrronium versus mometasone–indacaterol or twice-daily fluticasone–salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study

The lancet respiratory medicine, 2020-10, Vol.8 (10), p.1000-1012

2020

Volltextzugriff (PDF)

Once-daily mometasone plus indacaterol versus mometasone or twice-daily fluticasone plus salmeterol in patients with inadequately controlled asthma (PALLADIUM): a randomised, double-blind, triple-dummy, controlled phase 3 study

The lancet respiratory medicine, 2020-10, Vol.8 (10), p.987-999

2020

Volltextzugriff (PDF)

Cardiovascular safety of mometasone/indacaterol and mometasone/indacaterol/glycopyrronium once-daily fixed-dose combinations in asthma: pooled analysis of phase 3 trials

Respiratory medicine, 2021-04, Vol.180, p.106311-106311, Article 106311

2021

Volltextzugriff (PDF)

Long-term safety of once-daily indacaterol acetate/glycopyrronium bromide/mometasone furoate high-dose, and indacaterol acetate/mometasone furoate high-dose, in Japanese patients with inadequately controlled asthma: Results from two open-label, 52-week studies

The Journal of asthma, 2023-02, Vol.60 (2), p.403-411

2023

Volltextzugriff (PDF)

High performance germanium MOSFETs

Materials science & engineering. B, Solid-state materials for advanced technology, 2006-12, Vol.135 (3), p.242-249

2006

Volltextzugriff (PDF)

A Review of the Unique Drug Development Strategy of Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate: A First-in-Class, Once-Daily, Single-Inhaler, Fixed-Dose Combination Treatment for Asthma

Advances in therapy, 2022-06, Vol.39 (6), p.2365-2378

2022

Volltextzugriff (PDF)

Performance of the Cough and Sputum Assessment Questionnaire (CASA-Q) in COPD: Evidence from Clinical and Online Patient Interaction Studies

International Journal of Chronic Obstructive Pulmonary Disease, 2022-01, Vol.17, p.3087-3096

2022

Volltextzugriff (PDF)

Efficacy and safety of omalizumab in patients with moderate-to-severe asthma: An analytic comparison of data from randomized controlled trials between Chinese and Caucasians

Asian Pacific journal of allergy and immunology, 2022-09, Vol.40 (3), p.223-231

2022

Volltextzugriff (PDF)

Efficacy and safety of omalizumab in patients with moderate-to-severe asthma: An analytic comparison of data from randomized controlled trials between Chinese and Caucasians

Asian Pacific journal of allergy and immunology, 2022-09, Vol.40 (3), p.223-231

2022

Volltextzugriff (PDF)

True Random Number Generator Implemented in ReRAM Crossbar Based on Static Stochasticity of ReRAMs

2023 IEEE Asia Pacific Conference on Circuits and Systems (APCCAS), 2023, p.55-59

2023

Volltextzugriff (PDF)

Mometasone/Indacaterol/Glycopyrronium and FLU/SAL+ Tiotropium in Patients with Asthma

Journal of asthma and allergy, 2023-01, Vol.15, p.123

2023

Volltextzugriff (PDF)

Mometasone/Indacaterol/Glycopyrronium (MF/IND/GLY) and MF/IND at Different MF Strengths versus Fluticasone Propionate/Salmeterol Xinafoate (FLU/SAL) and FLU/SAL+ Tiotropium in Patients with Asthma

Journal of asthma and allergy, 2023-01, Vol.15, p.123

2023

Volltextzugriff (PDF)

Mometasone/Indacaterol/Glycopyrronium (MF/IND/GLY) and MF/IND at Different MF Strengths versus Fluticasone Propionate/Salmeterol Xinafoate (FLU/SAL) and FLU/SAL+ Tiotropium in Patients with Asthma

Journal of asthma and allergy, 2023-01, Vol.16, p.123-134

2023

Volltextzugriff (PDF)

Fevipiprant, an oral prostaglandin DP 2 receptor (CRTh2) antagonist, in allergic asthma uncontrolled on low-dose inhaled corticosteroids

The European respiratory journal, 2017-08, Vol.50 (2), p.1700670

2017

Volltextzugriff (PDF)

Implementation of RRAM based Swish Activation Function and its Derivative on 28nm FD-SOI

2022 International Electrical Engineering Congress (iEECON), 2022, p.1-4

2022

Volltextzugriff (PDF)

Modelling and Analysis of Multi-Junction Photovoltaic Cells

2020 IEEE 17th India Council International Conference (INDICON), 2020, p.1-6

2020

Volltextzugriff (PDF)

Embedded system with in-memory compute neuromorphic accelerator for multiple applications

Smart Embedded Systems, 2024, Vol.1, p.89-110

1, 2024

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(31)

Publikationsform

Sprache

Englisch
(41)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(21)
Life Sciences & Biomedicine
(12)
Asthma
(10)
Respiratory System
(8)
Humans
(6)
Photonic Band Gap
(6)
Physical Sciences
(6)
Technology
(6)
Clinical Trials
(5)
Engineering
(5)
Engineering, Electrical & Electronic
(5)
Palladium
(5)
Patients
(5)
Conducting Materials
(4)
Dielectric Materials
(4)
Germanium
(4)
Safety
(4)
Adult
(3)
Allergy
(3)
Applied Sciences
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Fevipiprant, an oral prostaglandin DP2 receptor (CRTh2) antagonist, in allergic asthma uncontrolled on low-dose inhaled corticosteroids

Ge (100) and (111) N- and P-FETs With High Mobility and Low- T Mobility Characterization

Ge-Interface Engineering With Ozone Oxidation for Low Interface-State Density

Ligelizumab treatment for severe asthma: learnings from the clinical development programme

One time a day mometasone/indacaterol fixed-dose combination versus two times a day fluticasone/salmeterol in patients with inadequately controlled asthma: pooled analysis from PALLADIUM and IRIDIUM studies

Confidence intervals for exposure‐adjusted rate differences in randomized trials

Periodic Analysis of Resistive Random Access Memory (RRAM)-Based Swish Activation Function

SiGe optoelectronic metal-oxide semiconductor field-effect transistor

Once-daily, single-inhaler mometasone–indacaterol–glycopyrronium versus mometasone–indacaterol or twice-daily fluticasone–salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study

Once-daily mometasone plus indacaterol versus mometasone or twice-daily fluticasone plus salmeterol in patients with inadequately controlled asthma (PALLADIUM): a randomised, double-blind, triple-dummy, controlled phase 3 study

Cardiovascular safety of mometasone/indacaterol and mometasone/indacaterol/glycopyrronium once-daily fixed-dose combinations in asthma: pooled analysis of phase 3 trials

Long-term safety of once-daily indacaterol acetate/glycopyrronium bromide/mometasone furoate high-dose, and indacaterol acetate/mometasone furoate high-dose, in Japanese patients with inadequately controlled asthma: Results from two open-label, 52-week studies

High performance germanium MOSFETs

A Review of the Unique Drug Development Strategy of Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate: A First-in-Class, Once-Daily, Single-Inhaler, Fixed-Dose Combination Treatment for Asthma

Performance of the Cough and Sputum Assessment Questionnaire (CASA-Q) in COPD: Evidence from Clinical and Online Patient Interaction Studies

Efficacy and safety of omalizumab in patients with moderate-to-severe asthma: An analytic comparison of data from randomized controlled trials between Chinese and Caucasians

Efficacy and safety of omalizumab in patients with moderate-to-severe asthma: An analytic comparison of data from randomized controlled trials between Chinese and Caucasians

True Random Number Generator Implemented in ReRAM Crossbar Based on Static Stochasticity of ReRAMs

Mometasone/Indacaterol/Glycopyrronium and FLU/SAL+ Tiotropium in Patients with Asthma

Mometasone/Indacaterol/Glycopyrronium (MF/IND/GLY) and MF/IND at Different MF Strengths versus Fluticasone Propionate/Salmeterol Xinafoate (FLU/SAL) and FLU/SAL+ Tiotropium in Patients with Asthma

Mometasone/Indacaterol/Glycopyrronium (MF/IND/GLY) and MF/IND at Different MF Strengths versus Fluticasone Propionate/Salmeterol Xinafoate (FLU/SAL) and FLU/SAL+ Tiotropium in Patients with Asthma

Fevipiprant, an oral prostaglandin DP 2 receptor (CRTh2) antagonist, in allergic asthma uncontrolled on low-dose inhaled corticosteroids

Implementation of RRAM based Swish Activation Function and its Derivative on 28nm FD-SOI

Modelling and Analysis of Multi-Junction Photovoltaic Cells

Embedded system with in-memory compute neuromorphic accelerator for multiple applications

Suchergebnisse filtern